MedTrace Logo

Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies

NCT05818020 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 269

Last updated 2024-06-26

No results posted yet for this study

Summary

This is multicentric, observational, and retro- prospective study.

Conditions

  • Biologic

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Nicola Normanno · IRCCS I.N.T. "G. Pascale"

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05818020 on ClinicalTrials.gov